Alto Neuroscience, Correlations

ANRO Stock   4.28  0.05  1.15%   
The current 90-days correlation between Alto Neuroscience, and Allient is 0.27 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alto Neuroscience, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alto Neuroscience, moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Alto Neuroscience, Correlation With Market

Weak diversification

The correlation between Alto Neuroscience, and DJI is 0.31 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Alto Neuroscience, and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alto Neuroscience,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Alto Stock, please use our How to Invest in Alto Neuroscience, guide.

Moving together with Alto Stock

  0.62VALN Valneva SE ADRPairCorr
  0.66FDMT 4D Molecular TherapeuticsPairCorr
  0.77JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.81LLY Eli Lilly Sell-off TrendPairCorr
  0.86MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.76PFE Pfizer Inc Aggressive PushPairCorr
  0.71SXTPW 60 Degrees PharmaceuPairCorr
  0.63BIAFW BioAffinity TechnologiesPairCorr
  0.62MREO Mereo BioPharma GroupPairCorr
  0.82NKTX Nkarta Inc Buyout TrendPairCorr
  0.83PEPG PepGenPairCorr
  0.61RGNX RegenxbioPairCorr
  0.74ADAP Adaptimmune TherapeuticsPairCorr
  0.67AMGN Amgen IncPairCorr

Moving against Alto Stock

  0.77BMY Bristol Myers Squibb Aggressive PushPairCorr
  0.76GILD Gilead SciencesPairCorr
  0.68NAMS NewAmsterdam PharmaPairCorr
  0.67PMVP Pmv PharmaceuticalsPairCorr
  0.59PHVS Pharvaris BVPairCorr
  0.56LPTX Leap TherapeuticsPairCorr
  0.52LPCN LipocinePairCorr
  0.38PLRX Pliant TherapeuticsPairCorr
  0.89SGMO Sangamo Therapeutics Buyout TrendPairCorr
  0.82CRVS Corvus PharmaceuticalsPairCorr
  0.8VREX Varex Imaging CorpPairCorr
  0.79AVTE Aerovate TherapeuticsPairCorr
  0.69CDXS CodexisPairCorr
  0.63AGIO Agios PharmPairCorr
  0.45SYRE Spyre Therapeutics Symbol ChangePairCorr
  0.4ANTX AN2 TherapeuticsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
ODFLSAIA
ODFLLIND
LINDSAIA
LINDALNT
ODFLALNT
ALNTSAIA
  
High negative correlations   
BCESAIA
BCEODFL
BCELIND
BCEALNT
BCEFIGI
FIGIODFL

Risk-Adjusted Indicators

There is a big difference between Alto Stock performing well and Alto Neuroscience, Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Alto Neuroscience,'s multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Alto Neuroscience, Corporate Management

Melissa BermanVice AccountingProfile
Michael MBAChief OfficerProfile
Jason HoffmanVice ResourcesProfile
Erin JDGeneral OfficerProfile